Onconetix, Inc. — Director's Dealing 2022

Feb 18, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-02-17

Reporting Person: Cincinnati Cornerstone Investors BWV I, LLC (10% Owner)
Reporting Person: Cincinnati Cornerstone Capital LLC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series Seed Preferred Stock	$1.5225		Common Stock (3611201)		Direct

Footnotes

F1: The Series Seed Preferred Stock is convertible at any time, at the holder's election, and has no expiration date; however, the Reporting Person has agreed to the automatic conversion of all of its Series Seed Preferred Stock and all related accrued and unpaid dividends into Common Stock on the closing of the initial public offering of the Issuer.

F2: Number of shares of Common Stock issuable upon the agreed upon automatic conversion of the Series Seed Preferred Stock and accrued and unpaid dividends on the closing of the initial public offering of the Issuer.

F3: Cincinnati Cornerstone Capital, LLC as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.